Page 1 | Search Results | Hematology, ASH Education Program

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Aaron T. Gerds

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 407–414.

https://doi.org/10.1182/hematology.2019000048

Published: 2019

Journal Articles

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

David C. Fajgenbaum

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 318–325.

https://doi.org/10.1182/asheducation-2018.1.318

Published: 2018

Journal Articles

Update from the latest WHO classification of MPNs: a user’s manual

Francesco Passamonti, Margherita Maffioli

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 534–542.

https://doi.org/10.1182/asheducation-2016.1.534

Published: 2016

Journal Articles

Beyond JAK inhibitor therapy in myelofibrosis

Olatoyosi Odenike

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 545–552.

https://doi.org/10.1182/asheducation-2013.1.545

Published: 2013

Journal Articles

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Stefan N. Constantinescu, William Vainchenker

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 553–560.

https://doi.org/10.1182/asheducation.V2012.1.553.3800163

Published: 2012

Journal Articles

Is there a role for the use of IFN-α in primary myelofibrosis?

Huong (Marie) Nguyen, Jean-Jacques Kiladjian

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 567–570.

https://doi.org/10.1182/asheducation.V2012.1.567.3806899

Published: 2012

Journal Articles

Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes

James W. Vardiman

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 199–204.

https://doi.org/10.1182/asheducation-2006.1.199

Published: 2006

Journal Articles

Sexuality and Fertility after Cancer

Leslie R. Schover

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 523–527.

https://doi.org/10.1182/asheducation-2005.1.523

Published: 2005

NARROW

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Update from the latest WHO classification of MPNs: a user’s manual

Beyond JAK inhibitor therapy in myelofibrosis

Small-molecule inhibitors in myeloproliferative neoplasms: are we aiming for the right targets?

Is there a role for the use of IFN-α in primary myelofibrosis?

Hematopathological Concepts and Controversies in the Diagnosis and Classification of Myelodysplastic Syndromes

Sexuality and Fertility after Cancer

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only